Search Results - Canney, Peter, MD

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial

    Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2... by Cameron, David, Prof, Morden, James P, MSc, Canney, Peter, MD, Velikova, Galina, MD, Coleman, Robert, Prof, Bartlett, John, PhD, Agrawal, Rajiv, FRCR, Banerji, Jane, BHealthSc, Bertelli, Gianfilippo, PhD, Bloomfield, David, MBBS, Brunt, A Murray, Prof, Earl, Helena, Prof, Ellis, Paul, Prof, Gaunt, Claire, BSc, Gillman, Alexa, BSc, Hearfield, Nicholas, BA, Laing, Robert, FRCR, Murray, Nicholas, FRCP, Couper, Niki, BSc, Stein, Robert C, Prof, Verrill, Mark, FRCP, Wardley, Andrew, Prof, Barrett-Lee, Peter, Prof, Bliss, Judith M, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial

    Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial by Ellis, Paul, Dr, Barrett-Lee, Peter, Prof, Johnson, Lindsay, BSc, Cameron, David, Prof, Wardley, Andrew, MD, O'Reilly, Susan, MD, Verrill, Mark, FRCP, Smith, Ian, Prof, Yarnold, John, Prof, Coleman, Robert, Prof, Earl, Helena, FRCP, Canney, Peter, MD, Twelves, Chris, Prof, Poole, Christopher, Prof, Bloomfield, David, FRCR, Hopwood, Penelope, Prof, Johnston, Stephen, FRCP, Dowsett, Mitchell, Prof, Bartlett, John MS, Prof, Ellis, Ian, Dr, Prof, Peckitt, Clare, MSc, Hall, Emma, PhD, Bliss, Judith M, Prof

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-label, randomised, phase 3 trial

    Addition of gemcitabine to paclitaxel, epirubicin, and cyclophosphamide adjuvant chemotherapy for women with early-stage breast cancer (tAnGo): final 10-year follow-up of an open-l... by Earl, Helena M, Professor, Hiller, Louise, PhD, Howard, Helen C, PhD, Dunn, Janet A, Prof, Young, Jennie, BA, Bowden, Sarah J, PhD, McDermaid, Michelle, Waterhouse, Anna K, BSc, Wilson, Gregory, FRCP, Agrawal, Rajiv, FRCR, O'Reilly, Susan, MD, Bowman, Angela, MB ChB, Ritchie, Diana M, MD, Goodman, Andrew, MB ChB, Hickish, Tamas, Prof, McAdam, Karen, FRCP, Cameron, David, Prof, Dodwell, David, Prof, Rea, Daniel W, FRCP, Caldas, Carlos, Prof, Provenzano, Elena, PhD, Abraham, Jean E, PhD, Canney, Peter, MD, Crown, John P, Prof, Kennedy, M John, Prof, Coleman, Robert, Prof, Leonard, Robert C, Prof, Carmichael, James A, MD, Wardley, Andrew M, Prof, Poole, Christopher J, Prof

    Published in The lancet oncology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: